The measure had little chance of consideration in the Senate, where it would need bipartisan support to move, but it ...

The Trump administration intends to make its most forceful attempt yet at restricting gender-affirming care for transgender ...

An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Whether you’ve searched the internet far and wide for the best ...

The Trump administration on Thursday moved to restrict gender-affirming care for minors across the country, threatening to cut federal funding from hospitals that offer treatments like puberty ...